Impact of proteogenomic evidence on clinical success
Karim, M. A.; Hukku, A.; Ariano, B.; Holzinger, E.; Tsepilov, Y.; Hayhurst, J.; Buniello, A.; McDonagh, E. M.; Castel, S. E.; Nelson, M. R.; Maranville, J.; Yerges-Armstrong, L.; Ghoussaini, M.
Show abstract
We assessed the impact of plasma protein quantitative trait loci (pQTL) on therapeutic hypotheses backed by human genetic evidence. We show that pQTL-supported target-indication pairs were 4.7 times more likely to advance from Phase I to launch, compared to a 2.6-fold increase observed only with human genetic evidence. Moreover, pQTL-based enrichment was prominent in druggable protein families which had limited enrichment from human genetic evidence alone.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.